ob0008p49 | Original Research
ob0008p50 | Original Research
ob0008p51 | Original Research
ob0008p52 | Original Research
ob0008p53 | Original Research
ob0008p54 | Original Research
ob0008p55 | Original Research
ob0008p56 | Original Research
ob0008p57 | Original Research
ob0008p58 | Original Research
ob0008p59 | Original Research
ob0008p60 | Original Research
ob0008p61 | Original Research
ob0008p62 | Original Research
ob0008p63 | Original Research
ob0008p64 | Original Research
Romosozumab uptake across Trusts and Health Boards in England, Wales and Northern Ireland from 2022 to 2025
ob0008p65 | Original Research
ob0008p66 | Original Research
ob0008p67 | Original Research
ob0008p68 | Original Research
ob0008p69 | Original Research
ob0008p70 | Original Research
ob0008p71 | Original Research
ob0008p72 | Original Research
ob0008p73 | Original Research
ob0008p74 | Original Research
ob0008p75 | Original Research
ob0008p76 | Original Research
ob0008p77 | Original Research
ob0008p78 | Original Research
ob0008p79 | Original Research
ob0008p80 | Original Research